Cargando…
LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells
Non-small-cell lung cancer (NSCLC) is defined as the most universally diagnosed class of lung cancer. Cisplatin (DDP) is an effective drug for NSCLC, but tumors are prone to drug resistance. The current study set out to evaluate the regulatory effect of long non-coding RNA (lncRNA) small nucleolar R...
Autores principales: | Tan, Deli, Li, Gang, Zhang, Peng, Peng, Chao, He, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805932/ https://www.ncbi.nlm.nih.gov/pubmed/35014944 http://dx.doi.org/10.1080/21655979.2021.2018099 |
Ejemplares similares
-
LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity
por: She, Kelin, et al.
Publicado: (2023) -
LncRNA SNHG12 ameliorates brain microvascular endothelial cell injury by targeting miR-199a
por: Long, Fa-Qing, et al.
Publicado: (2018) -
LncRNA SNHG12 promotes cell growth and inhibits cell apoptosis in colorectal cancer cells
por: Wang, J.Z., et al.
Publicado: (2017) -
SNHG12: An LncRNA as a Potential Therapeutic Target and Biomarker for Human Cancer
por: Tamang, Suraksha, et al.
Publicado: (2019) -
LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival
por: Liang, Meng, et al.
Publicado: (2020)